Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth

University of Colorado, Denver90 enrolled

Overview

To evaluate the effect of estradiol with or without a prior gonadotropin releasing hormone analogue on insulin sensitivity and vascular function in transgender females compared to cisgender controls.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Transgenderism Gender Dysphoria Insulin Sensitivity

Eligibility

Sex: ALLMin age: 13 YearsMax age: 16 Years

Medical Language ↔ Plain English

Inclusion Criteria (transgender females): * Identify as a transgender female * Age 13-16 years at the time of enrollment * If on a gonadotropin releasing hormone analogue, \> 6 months exposure * Plan to start estradiol clinically in \< 4 months Inclusion Criteria (cisgender males and females): * Males and females ages 13-16 years Exclusion Criteria: * Cognitive, psychiatric, or physical impairment resulting in inability to tolerate the study procedures * Antipsychotic medication use * Type 1 or 2 diabetes (by medical history) * Polycystic ovarian syndrome (PCOS for cisgender females) * Hypertension (resting BP ≥ 140/90 mm/Hg) * Weight\> 400 lbs * On oral progesterone medications (including oral progesterone or progestin, combined oral contraceptives or etonogestrel implant) * Pregnancy (for cisgender females)

Locations (1)

Children's Hospital Colorado

Aurora, Colorado, United States

RECRUITING